Estarylla® (Norgestimate and Ethinyl Estradiol Tablets, USP) (generic ORTHO CYCLEN®)

0.25 mg Norgestimate /0.035 mg Ethinyl Estradiol

$15/ 3 blister packs of 28 tablets

FDA approved

$99.00

Product Details

Estarylla® (norgestimate and ethinyl estradiol tablets, USP), are an estrogen/progestin COCs, indicated for use by women to prevent pregnancy. Estarylla consists of 28 round tablets of 21 blue tablets each containing 0.25 mg norgestimate and 0.035 mg ethinyl estradiol and 7 green tablets (inert).
For information on how to take Estarylla click here.

What to Expect

In three US clinical trials with norgestimate and ethinyl estradiol, 1,651 women aged 18 to 38 years were studied for up to 24 cycles, proving a total of 24,272 cycles of exposure. The pregnancy rate was approximately 1 pregnancy per 100 women-years.

Select Safety Information

Stop Estarylla if an arterial thrombotic event or venous thromboembolic (VTE) event occurs. Stop Estarylla estradiol if there is unexplained loss of vision, proptosis, diplopia, papilledema, or retinal vascular lesions. Evaluate for retinal vein thrombosis immediately. Estarylla is contraindicated in females over 35 years old who smoke. Advise the nursing mother to use other forms of contraception, when possible, until she has weaned her child. COCs can reduce milk production in breastfeeding mothers. This product (like all oral contraceptives) is intended to prevent pregnancy. It does not protect against HIV infection (AIDS) and other sexually transmitted diseases. Please click here for the complete boxed warning & for more Important Risk Information.
Please click here for full Prescribing Information and Patient Information.

Category: